Innovating Together to Make a Difference

PTx is dedicated to developing and commercializing innovative therapies that address significant unmet needs for patients. Building upon a strong foundation of expertise in oncology, PTx also leads and supports groundbreaking research in infectious disease and other areas of clinical urgency, including treatment of the novel coronavirus (COVID-19).

With integrated capabilities in research, manufacturing, development, and commercialization, the PTx team works rapidly to bring therapies to patients who need them most around the world. This focus on collaboration and partnership enables us to move development programs forward with an efficient and streamlined approach.

The Patient Is Our Priority

PTx begins with a focus on the health challenges that present the biggest detriment to patients. From there, we develop and assess every aspect of a product and its development on the ability to preserve and improve patient health and quality of life. We also provide educational resources, support programs, and financial assistance for our therapies to help more patients access treatment safely, effectively and affordably.

A Partner for Better Health

Making a difference is a team effort. PTx recognizes the crucial role of all stakeholders, including clinicians, medical centers, insurers, regulatory agencies, and policy makers, in advancing healthcare solutions and patient care.  We partner with leading companies, research centers, and investigators to ensure our products are tested in the best settings and developed to meet the highest rigors of science and patient care.

By engaging with a diverse range of participants who shape both clinical research and healthcare delivery, we are confident in our ability to better keep research and development programs moving ahead in an increasingly complex healthcare environment.

Great Partners. Great Medicines. Great Outcomes.